United Vein & Vascular Centers (UVVC), a national leader in minimally invasive vein and vascular care, is proud to announce the official opening of its newest clinic in Rockwall, Texas, expanding ...

Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.

Sarawak has reached a new milestone in advanced cardiac care with the successful completion of the first EPi-Sense hybrid ...

After approval in late 2024, Johnson & Johnson's Varipulse PFA system started 2025 on the wrong foot: Its early rollout had ...

After claiming its approval in Europe earlier this year, Abbott has secured the FDA’s go-ahead for its Volt pulsed field ablation system for irregular heart rhythms, a step forward in an | With the U.

United Vein & Vascular Centers (UVVC), a national leader in minimally invasive vein and vascular care, is proud to announce the opening of its newest clinic in Douglasville, Georgia, expanding access ...

Boston Scientific ($BSX) announced an update on their ongoing clinical study. Study OverviewThis global Boston Scientific trial, officially titled ...

Pulse Biosciences, Inc. , a company leveraging its novel nPulsetm technology using its proprietary Nanosecond Pulsed Field Ablationtm (nanosecond PFA or nsPFAtm) energy, today announced that the U.S.

Pulse Biosciences PLSE recently announced that the FDA has granted Investigational Device Exemption (“IDE”) approval to ...

Here are the largest medtech funding rounds — all of which equaled or exceeded $150 million — of 2025: Waltham, Massachusetts ...

FDA approvals in 2025 introduced novel therapies and devices across ophthalmic subspecialties, emphasizing sustained efficacy ...

Medications are the first-line treatment for atrial fibrillation, or A-fib. When they begin to fail, one option is ablation.